Oppenheimer Asset Management’s Puma Biotechnology PBYI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-29,815	Closed	-$209K	–	1247
2021 Q3	$209K	Buy	29,815 +1,710	+6%	+$12.8K	﹤0.01%	1134
2021 Q2	$258K	Sell	28,105 -10,444	-27%	-$106K	﹤0.01%	1091
2021 Q1	$375K	Buy	38,549 +801	+2%	+$8.95K	0.01%	985
2020 Q4	$387K	Buy	37,748 +897	+2%	+$9.08K	0.01%	941
2020 Q3	$372K	Buy	36,851 +11,082	+43%	+$113K	0.01%	878
2020 Q2	$269K	Buy	25,769 +8,754	+51%	+$90.6K	0.01%	962
2020 Q1	$144K	Buy	17,015 +7,110	+72%	+$69.1K	﹤0.01%	1037
2019 Q4	$87K	Buy	9,905 +384	+4%	+$3.18K	﹤0.01%	1235
2019 Q3	$102K	Buy	9,521 +2,737	+40%	+$29.6K	﹤0.01%	1182
2019 Q2	$86K	Buy	6,784 +307	+5%	+$7.07K	﹤0.01%	1261
2019 Q1	$251K	Buy	6,477 +1,454	+29%	+$44.4K	0.01%	978
2018 Q4	$102K	Buy	5,023 +367	+8%	+$11K	﹤0.01%	1185
2018 Q3	$213K	Buy	+4,656	New	+$224K	﹤0.01%	1067
2017 Q4	–	Sell	-241	Closed	-$29K	–	1370
2017 Q3	$29K	Sell	241 -32	-12%	-$2.98K	﹤0.01%	1457
2017 Q2	$24K	Sell	273 -150	-35%	-$8.39K	﹤0.01%	1459
2017 Q1	$16K	Buy	+423	New	+$15.4K	﹤0.01%	1495